Creative Medical Technology price to sales ratio CELZ

Market value divided by revenue over the last twelve months, since 2018.

Today, Oct 23, 2026: n/m; a sliver of sales
Last meaningful: 82.8×; Nov 2023
8-year median: 62.3×
8-year range: 0.3× to 195×
Peer median: 1.4×

Creative Medical Technology's price to sales ratio is not a meaningful number today: a multiple this high rests on a sliver of sales.

It was last meaningful in Nov 2023, at 82.8×.

On the days it had one over the last 8 years, its median was 62.3×, from 0.3× in Mar 2020 to 195× in Apr 2022.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2023	82.8×	42.9×	119×
2022	38.9×	37.0×	195×
2021	n/m a value too high to mean anything
2020	1.4×	0.3×	5.4×
2019	3.2×	2.6×	145×
2018	85.3×	85.3×	182×

Against its peers

Companies in Healthcare nearest Creative Medical Technology's size, closest first, today.

Company	Price to sales ratio
CELZCreative Medical Technology	n/m
OXBROXBRIDGE RE HOLDINGS	2.8×
EDUCEducational Development	0.4×
GTIMGood Times Restaurants	0.1×
MDRRMedalist Diversified	1.6×
BCGBinah Capital	0.1×
VIPVulcan Infrastructure & Power	0.4×
MXCMexco Energy	3.0×
CKXCKX Lands	31.0×
MSGMMotorsport Games	1.5×
ATCHAtlasClear	1.2×
Peer median	1.4×

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Creative Medical Technology

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.